The report initiates coverage on Molbio Diagnostics with a BUY rating, CMP INR 1,503 and TP INR 1,800, citing its Truenat platform, 12,500+ devices in 90+ countries, and an estimated 23% revenue CAGR and 50% PAT CAGR over FY26-29.
Read this note →Research notes
What India's research desks published, reported with attribution and linked to the original notes. Orivam issues no recommendations of its own.
All houses
HDFC Securities
Motilal Oswal
Mirae Asset Sharekhan
Tata Asset Management
India IPO
Jainam
GEPL Capital
Way2Wealth
SBICAP Securities
Angel One
Axis Securities
ICICI Direct Research Retail
Formerly known as Way2Wealth
Religare
Arete Securities
ICICI Direct
Way2Wealth Securities
ICICI Securities
quant Mutual Fund
Kotak Securities
JM Financial
ICICI Securities – Retail
Ventura Securities
Global Markets by Vested
Prabhudas Lilladher
ITC Hotels
Elara Securities
Exterminators PLC
Emkay Global
Industrial Asphalts
Private Client Group Research summarized from KIE research report
Kahawatte Plantations PLC
2548 notes · all time
The report states Shiva Cement, JSW Cement's listed subsidiary, will merge into JSW Cement, with Shiva shareholders getting 5 JSW Cement shares for every 41 Shiva shares.
Read this note →The report notes hikes in long product, flat steel and alloy steel round bar prices effective 1 Oct'26, with a Positive view.
Read this note →The report states IndusInd Bank's 2QFY27 net advances grew 11.2% YoY beating estimates while deposits rose 10.1% YoY missing estimates, with CASA ratio falling to 28.0% and FCNR(B) mobilization of USD3.51b supporting growth, with a Positive view.
Read this note →The report states Axis Bank's 2QFY27 gross advances grew 22.7% YoY beating estimates while deposits grew 20.7% YoY missing estimates, with CASA mix falling to 36.5% and CD ratio rising to 95.4%, with a Positive view.
Read this note →The report notes Kotak's 2QFY27 net advances grew 24.7% YoY and deposits 23.2% YoY, both above estimates, with CASA ratio falling to 38.2% and CD ratio easing to 88.6%, and states the view as Positive.
Read this note →The technical snapshot lists the stock as a bearish intraday view at a CMP of 3,558.8 with support at 3,488 and resistance at 3,594.
Read this note →The technical snapshot lists the stock as a bullish intraday view at a CMP of 557 with support at 551 and resistance at 568.
Read this note →The note says the company expects exports to remain at 15%-20% of revenue while domestic business continues growing 14%-15%.
Read this note →The note says the company signed a master restructuring agreement with National Asset Reconstruction Co, with outstanding debt at Rs 3,736 crore.
Read this note →The note says the company launched eight ayurvedic healthcare and wellness products.
Read this note →The note says the company partnered with MSN to launch Riociguat Tablets in the US for treatment of recurrent CTEPH.
Read this note →The note says arm ACME Renewtech commissioned an additional 66.68 MW of solar capacity at Bikaner, taking commissioned capacity to 133.36 MW of a 300 MW hybrid project.
Read this note →The note says the company has added 1,694 MW of capacity since April, taking total installed capacity to 15.1 GW.
Read this note →The note says the company signed a binding MoU with Imagicaaworld Entertainment to acquire a Khopoli hotel for Rs 248 crore.
Read this note →The note says the company entered an operations and management agreement with Mission of Mercy Hospital & Research Centre and that its Girinagar Hospital, Bengaluru commenced commercial operations.
Read this note →The note says the company received a Rs 73 crore HTLS reconductoring order from Power Grid.
Read this note →The note says Q2 total average deposits rose 18.8% YoY to Rs 6.06 lakh crore, net average advances rose 22.1% YoY to Rs 5.47 lakh crore and average CASA rose 14.2% YoY to Rs 2.26 lakh crore.
Read this note →The technical section rates KALYANKJIL as BULLISH intraday with CMP 557, support 551 and resistance 568.
Read this note →The technical section rates DMART as BEARISH intraday with CMP 3558.8, support 3488 and resistance 3594.
Read this note →The note states the company expects exports to remain at 15%-20% of revenue while the domestic business continues growing 14%-15%.
Read this note →The note states the company signed a master restructuring agreement with National Asset Reconstruction Co with outstanding debt at Rs 3,736 crore.
Read this note →The note states the company launched eight ayurvedic healthcare and wellness products.
Read this note →The note states the company partnered with MSN to launch Riociguat Tablets in the US for treatment of recurrent CTEPH.
Read this note →The note states ACME Renewtech commissioned an additional 66.68 MW solar capacity at Bikaner, reaching 133.36 MW of a 300 MW hybrid project.
Read this note →